If you are an Aviation Medical Examiner, you have almost certainly had this scenario play out. A pilot walks into your office for their medical exam, you flag concerns for sleep apnea, and you know a sleep study is the next step. What you may be less certain about is which type of study to recommend and where at-home Type II testing fits into your referral pathway.
The landscape has changed. In-lab polysomnography used to be the default because that was where the comprehensive data lived. Today, Type II at-home testing provides the same level of clinical data as an in-lab study, in a format that works better for pilots and streamlines the FAA process. This piece is a quick overview for AMEs on what the option looks like, how it fits your workflow, and why more of your colleagues are recommending it.
Why Type II Matters (and Why Type III Does Not Always Work)
You already know the FAA’s sleep apnea protocol expects comprehensive data. For most pilot cases, that means Type II or Type I level detail: full sleep architecture, EEG, EOG, EMG, respiratory effort, oxygen saturation, and body position.
Type III at-home tests, which measure breathing, oxygen, and heart rate, are common in the general adult population for confirming obstructive sleep apnea. But for pilots seeking or maintaining FAA medical certification, Type III often leaves gaps that lead to deferrals. When the FAA cannot see the full clinical picture, they typically request additional data, and your patient’s certification timeline extends.
Type II fills that gap without the friction of an in-lab study. Same data depth, dramatically better patient experience, faster turnaround.
What the AME Workflow Looks Like with At-Home Type II
For AMEs considering referring patients to a Type II provider, the workflow is straightforward:
The patient orders the study directly or through your referral. The kit ships to their home within a few days. The patient completes the study in their own bed on a single night, following simple written instructions for device application. They return the device by prepaid shipping. A board-certified sleep physician scores the study and produces an FAA-compliant report, typically within three to five business days of device return.
From your side, that means less coordination, fewer follow-up phone calls from patients trying to schedule around their flight schedule, and a report you can rely on for FAA submission without having to request revisions or additional data.
Common Questions AMEs Ask
Is at-home Type II testing really FAA-compliant? Yes, when the study is scored by a board-certified sleep physician and the report includes the required elements. AHI, sleep staging, oxygen desaturation events, and clinical interpretation all need to be present in the format the FAA’s medical reviewers expect. A properly delivered Type II study is functionally equivalent to an in-lab polysomnogram from the FAA’s perspective.
How accurate is the data compared to in-lab? For a properly applied Type II study, the accuracy is comparable to in-lab polysomnography. Patients sleeping in their own environment often produce results that better reflect their typical sleep patterns, which is clinically relevant. Studies have been validating this equivalence for over a decade.
What if the patient has a technical failure during the study? Modern Type II devices are designed for patient self-application and include quality checks. Failed studies are rare, and when they do occur, most providers will resend a replacement kit at no additional charge. Redo rates are low.
Do I need to change how I document the referral? No. Type II at-home testing fits into the same referral pathway you already use. The only difference is where the study takes place and how the data is collected.
Why More AMEs are Recommending It for Pilots
Pilots have unpredictable schedules. Coordinating a lab night can push a study out by weeks, especially for line pilots on rotation. At-home Type II removes that scheduling friction almost entirely.
There is also a compliance benefit. Pilots are far more likely to complete a study when it happens in their own bed on their own timeline. In-lab studies have measurable no-show and cancellation rates. At-home Type II does not.
Finally, the FAA-compliant reporting means fewer deferrals for missing data. That is a win for the patient and a win for your practice, because you spend less time on back-and-forth with the FAA on incomplete documentation.
How ESD Fits In
At ESD, we work exclusively in Type II at-home sleep testing for pilots. Every study we deliver is scored by a board-certified sleep physician and formatted to the FAA’s typical documentation standards from the first submission.
Just as importantly, Dave and the ESD team have spent years working alongside AMEs and pilots. We understand the referral workflow, the special issuance process, and the questions that come up when a pilot lands in your office concerned about their medical. If you have a case you want to talk through or a patient who could use guidance, we are a phone call away.
If you are an AME who would like to learn more about how at-home Type II testing could fit into your referral workflow, reach out. We are always happy to talk shop with fellow medical professionals.